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ABSTRACT 
A major challenge to most countries is the growing cost of healthcare. The cost of laboratory 
testing is approximately 3% of the total clinical costs. On the other hand, waste from 
inappropriate admissions to clinical departments is reported to be as high as 15%. A frequently 
used approach to save dollars in healthcare is the random reduction in the budget for laboratories, 
with a focus on reduction of the number of unnecessary laboratory tests. The World Health 
Assembly has approached the problem by publishing a list of essential in vitro diagnostic tests, in 
order to achieve a global rationalization of the problem. 
A much more thoughtful strategy to saving healthcare finance is to improve the efficiency of the 
diagnostic process.  This report presents an opportunity to reduce diagnostic error and increase 
the efficiency of diagnostic testing. Reduction in time to a correct diagnosis provides a major 
financial as well as a clinical benefit. In addition, reducing both overutilization and 
underutilization of laboratory tests while achieving the correct diagnosis is a major benefit to 
challenged healthcare budgets. 
One approach taken to achieve major savings in healthcare has been the creation of “Diagnostic 
Management Teams,” composed of experts in specialty areas of medicine who are primarily 
based in the clinical laboratory to advise physicians on the selection of only necessary tests and 
the interpretation of complex test results. 
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INTRODUCTION 
The Global Problem of Diagnostic Error 
At the World Health Assembly, there is continuous discussion about the use of financial resources 
to promote health and well-being.  Despite the large number of deaths from diagnostic errors, there 
is still limited awareness of the mortality and morbidity reduction that could occur with an 
investment to improve the accuracy and speed of diagnoses [1].  It has long been stated that 
information from clinical laboratory tests accounts for as much as 70% of the diagnoses that are 
made.  When considering the accompanying diagnostic areas of anatomic pathology and radiology, 
the percent of diagnoses established by using information from one or more of these areas in 
industrialized countries where they are readily available is likely to approach 90%.   
The growth of genetic testing is now allowing identification of disorders that were either 
undiagnosed or misdiagnosed, and therefore not effectively treated.  The area of genetic testing 
that permits identification of effective drugs, called pharmacogenomics, is expanding dramatically.  
Treatment with the right drug at the right time often depends upon performance of a genetic 
laboratory test initially, and the recognition of this opportunity for more effective drug therapy 
with laboratory testing is still quite limited across the globe.   
Alongside the improvement in clinical outcome that could be realized by modest investments in 
the diagnostic process are the tremendous financial benefits from achieving an accurate diagnosis 
rapidly.  The reduction in expenditures resulting from shortened time to effective treatment and 
shortened length of stay for hospitalized patients far exceeds the dollars spent on testing, no matter 
how healthcare is paid for in different countries.  Complications of diseases and the requirement 
to treat advanced disease rather than early disease are both extremely expensive [2, 3].  The 
response of many hospital leaders, particularly those without clinical experience, is to invoke 
universal reductions and expenditures, without any understanding that a missed or delayed 
diagnosis is associated with losses in other budgets outside the diagnostic specialties [4]. 
Importantly, the citizens of most countries across the globe are largely unaware that poor clinical 
outcomes could be prevented if the diagnostic process were improved.  Healthcare providers in 
many countries can lose patients, and therefore income, if they reveal to their patients that they 
were responsible for a diagnostic error.  Procedural errors, such as removing the wrong kidney in 
a case of renal carcinoma, or treatment with the wrong dose of a drug are easily recognized causes 
of mortality and morbidity, but this is not so for the much larger number of errors related to 
establishing a diagnosis [2].  While there has been much attention to improving processes to reduce 
procedural errors, in most countries there is little if anything that would help make institutions and 
individual healthcare providers aware that they have made a diagnostic mistake and that a poor 
outcome is attributable to their incorrect selection of diagnostic tests or their failure to interpret 
the results of diagnostic tests correctly [3] (Fig. 1). 
 
THE PROBLEM OF DIAGNOSTIC ERROR IN THE UNITED STATESIn the United 
States, many incentives in the diagnosis and treatment of patients that enable diagnostic error [5].  
The abundance of lawsuits for medical mistakes creates a defensive position among healthcare 
providers.  This prompts unnecessary “defensive” testing. The lack of attention to laboratory 
medicine in medical school [6], and for those in practice, produces more than 10,000 new 
physicians in the United States who “do not know what they do not know.”  The United States also 
suffers from substantial payment for diagnoses in anatomic pathology and in radiology, but little 
payment for establishing a diagnosis in laboratory medicine.  This has resulted in having few 
experts able to help clinicians order the correct laboratory tests and interpret the results correctly.  
A recent report [7]  identified the barriers to widespread use of experts consultation services 
through a diagnostic management team in the United States. 
 
THE PROBLEM OF DIAGNOSTIC ERROR IN ITALY 
Currently, the Italian government is conducting a review of its healthcare spending.  Many of these 
reductions in expenditures include activities in the clinical laboratory, and the steps being taken 
are compromising the speed and accuracy of diagnoses.  In Italy, as in other countries, 
improvement in diagnostic services that cost little can save thousands to millions of euros.  For 
example, in Italy where thalassemia is common, the clinical center in Rome for patients with 
thalassemia and other anemias was recently closed.  The proposed savings from this closure of 
approximately €10 million annually is likely to lead to much larger healthcare costs for this patient 
population who are now less likely to be identified and, even if identified, less likely receive the 
correct treatment.  It will be impossible to calculate the costs of these losses in diagnostic and 
treatment support for these patients. Although Italy may have different obstacles to rapidly 
establishing and accurate diagnosis that are present in the United States, the number of obstacles 
is still substantial enough to require a major infrastructure development in the countries healthcare 
delivery system.  The barriers to diagnostic management team implementation in Italy are more 
similar than different from those in the United States. 
 
AN OPTION TO IMPROVE THE SPEED AND ACCURACY OF DIAGNOSES IN BOTH 
COUNTRIES 
In the United States, over the past 20 years but most prominently in the past few years, teams of 
diagnostic experts have been forming to support clinical colleagues who are in direct contact with 
patients.  These teams, known as diagnostic management teamsprovide advice on laboratory test 
selection and test result interpretation [8-10].  The experts have updated information about 
diagnoses in specialized areas, for example, in bleeding and clotting disorders.  When experts can 
provide information while clinical decisions are being made, in a local or distant environment from 
the healthcare provider seeing the patient, the likelihood for an efficient diagnostic process is 
substantially increased.  Communication between the diagnostic management team and the 
treating health care provider is becoming simpler and it now allows for back and forth questioning 
until a diagnosis is achieved.  When the diagnosis is established, the patient is ready for treatment, 
and the most up-to-date information from those who read the latest journals in their specialty, is 
now available.  Diagnostic management teams have been created and successfully implemented in 
many areas, including coagulation, leukemia and lymphoma, transfusion medicine, 
microbiology/infectious disease, and even to review cases of presumed child abuse for the 
presence of an underlying bleeding disorder. 
At Vanderbilt University in Nashville, TN, USA, the diagnostic management team in coagulation 
was able to dramatically decrease the length of stay and the cost of care for patients with pulmonary 
embolism and for patients with intracranial hemorrhage [11].  The diagnostic management team 
for patients with leukemia and lymphoma in that same institution has improved the speed and 
accuracy of the diagnosis of hematologic malignancies [8]. 
There is now global interest in the creation of diagnostic management teams.  Recent conferences 
focused on the creation of diagnostic management teamsin Galveston, TX, USA, in 2017 and 2018 
have been held, and the information from these meetings has spread globally.  Healthcare delivery 
and payment for healthcare varies significantly from country to country.  However, a constant 
finding in all countries, both industrialized and non-industrialized, is the abundance of barriers to 
establishing a rapid and accurate diagnosis.  The specific barriers may be different from one 
country to another, but in each country there are many.  The implementation of diagnostic 
management teams across the globe has the opportunity to remove many of the obstacles to 
achieving a rapid and correct diagnosis by providing expert recommendations on test selection and 
results interpretation in real time. 
The first essential in vitro diagnostics list was released by the World Health Organization in May 
2017, as a recognition of the importance of diagnosis before treatment. It includes more than 100 
tests and will increase every year to guide countries on appropriate test selection [12,13]. 
CONCLUSIONS 
The need for communication between healthcare providers in direct contact with patients and 
expert diagnosticians is extremely high, and the need is growing as more complex genetic results 
are appearing in the clinical records of patients.  The challenges to generate an accurate and rapid 
diagnosis are exemplified by the situations in the United States and Italy, and most likely reflect a 
global need as diagnostic information becomes more abundant and more expensive. 
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